Get the Stockscreener App
7.99
3.87%
0.298
111 Inc Adr stock is traded at $7.99, with a volume of 29,655.
It is up +3.87% in the last 24 hours and up +18.55% over the past month.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
See More
Previous Close:
$7.692
Open:
$7.9678
24h Volume:
29,655
Relative Volume:
1.14
Market Cap:
$72.81M
Revenue:
$2.05B
Net Income/Loss:
$-45.99M
P/E Ratio:
-14.18
EPS:
-0.5634
Net Cash Flow:
$5.54M
1W Performance:
-4.88%
1M Performance:
+18.55%
6M Performance:
+15.80%
1Y Performance:
-29.91%
1-Day Range:
$7.20
$8.00
1-Week Range:
$7.20
$8.38
52-Week Range:
$4.145
$14.10
111 Inc Adr Stock (YI) Company Profile
Compare YI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YI
111 Inc Adr
|
7.99 | 72.81M | 2.05B | -45.99M | 5.54M | -0.5634 |
|
MCK
Mckesson Corporation
|
693.46 | 88.78B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
283.00 | 56.59B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
148.22 | 35.69B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
68.64 | 7.95B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.01 | 580.18M | 10.42B | -38.77M | 323.54M | -0.51 |
111 Inc Adr Stock (YI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Resumed | Citigroup | Buy |
111 Inc Adr Stock (YI) Latest News
Hims Earnings Reveal Massive 111% Growth as Digital Health Platform Targets $6.5B Revenue by 2030 - Stock Titan
111, Inc. (NASDAQ:YI) Shares Bought by JPMorgan Chase & Co. - Defense World
111 (NASDAQ:YI) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Meixler Investment Management Ltd. Sells 111 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World
Federated Hermes Inc. Purchases 111 Shares of Cable One, Inc. (NYSE:CABO) - Defense World
Short Interest in 111, Inc. (NASDAQ:YI) Drops By 54.5% - Defense World
Bezos Bets Big: Slate Auto Quietly Raises $111M Series A To Build $25K EV Truck, Eyes 2026 Launch In Indianapolis - Yahoo Finance
111 Shares in AutoZone, Inc. (NYSE:AZO) Purchased by Wedbush Securities Inc. - MarketBeat
111’s (YI) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
American Century Companies Inc. Sells 111 Shares of CGI Inc. (NYSE:GIB) - Defense World
Klein Pavlis & Peasley Financial Inc. Sells 111 Shares of Microsoft Co. (NASDAQ:MSFT) - Defense World
Orion Portfolio Solutions LLC Purchases 111 Shares of AutoZone, Inc. (NYSE:AZO) - MarketBeat
Short Interest in 111, Inc. (NASDAQ:YI) Expands By 94.1% - Defense World
Weiss Ratings Reiterates Sell (D-) Rating for 111 (NASDAQ:YI) - Defense World
Earnings call transcript: 111 Inc Q4 2024 sees stock rise despite revenue miss By Investing.com - Investing.com South Africa
Earnings call transcript: 111 Inc Q4 2024 sees stock rise despite revenue miss - Investing.com India
, the announcement signifies the company’s compliance with SEC regulations and its commitment to transparency with its financial reporting. - Investing.com India
111 Inc Makes History: Turns First-Ever Profit as Operating Costs Plunge 470 Basis Points - Stock Titan
111 Inc CEO Reveals 2025 Growth Strategy: Exclusive Analyst Discussion on Q4 Performance - StockTitan
111 (NASDAQ:YI) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Ithaca Energy plc (LON:ITH) Insider Yaniv Friedman Buys 111 Shares of Stock - Defense World
Trump wants Republicans to 'get rid of' the CHIPS Act. They may just ignore him. - Business Insider
The New York Times Company Privacy Policy - The New York Times
Seaside Wealth Management Inc. Purchases 111 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World
111, Inc. (NASDAQ:YI) Sees Significant Drop in Short Interest - The AM Reporter
111, Inc. (NASDAQ:YI) Short Interest Update - Defense World
New York State Teachers Retirement System Sells 111 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) - Defense World
Allspring Global Investments Holdings LLC Sells 111 Shares of Insulet Co. (NASDAQ:PODD) - Defense World
Obituary for Tom Lamar Beauchamp III - sagelbloomfield.com
When Will 111's Healthcare Platform Report Q4 Earnings? Key Details for Investors - StockTitan
111 (NASDAQ:YI) Earns Sell (E+) Rating from Weiss Ratings - Defense World
111 (NASDAQ:YI) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat
Savant Capital LLC Buys 111 Shares of Essex Property Trust, Inc. (NYSE:ESS) - Defense World
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) - GlobeNewswire
111, Inc. (NASDAQ:YI) Sees Significant Increase in Short Interest - MarketBeat
65 thoughts on “VanZandt III, Edward Leonard” - kutisfuneralhomes.com
Airbnb Stock Jumps 15% on Strong Earnings and Revenue - Wall Street Pit
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
111 Inc regains Nasdaq compliance with share price By Investing.com - Investing.com South Africa
111, Inc. meets NASDAQ's listing standards again - Investing.com
111, Inc. Regains NASDAQ Compliance - TipRanks
111 Inc regains Nasdaq compliance with share price - Investing.com
Chinese Healthcare Giant 111, Inc. Defeats Delisting Threat as NASDAQ Confirms Compliance - StockTitan
Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension - BioSpace
Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustaine - GlobeNewswire
United Parcel Service, Inc (UPS)’s Day in Review: Closing at 111.29, Down by -2.57 - The Dwinnex
111’s (YI) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
Iqiyi Likely to Experience Long-Term Headwinds as Challenges Remain Over Subscriber Growth - Morningstar
111, Inc. (NASDAQ:YI) Sees Large Decline in Short Interest - MarketBeat
Short Interest in 111, Inc. (NASDAQ:YI) Expands By 167.4% - Defense World
King Charles III | Biography, Prince, Wife, Cancer, & Age - Britannica
111 Inc Adr Stock (YI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):